The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Open accessAbstract
Summary We report a comprehensive molecular characterization of pheochromocytomas and paragangliomas (PCC/PGLs), a rare tumor type. Multi-platform integration revealed that PCC/PGLs are driven by diverse alterations affecting multiple genes and pathways. Pathogenic germline mutations occurred in eight PCC/PGL susceptibility genes. We identified CSDE1 as a somatically-mutated driver gene, complementing four known drivers (HRAS, RET, EPAS1, NF1). We also discovered fusion genes in PCC/PGL, involving MAML3, BRAF, NGFR and NF1. Integrated analysis classified PCC/PGLs into four molecularly-defined groups: a kinase signaling subtype, a pseudohypoxia subtype, a Wnt-altered subtype, driven by MAML3 and CSDE1, and a cortical admixture subtype. Correlates of metastatic PCC/PGL included the MAML3 fusion gene. This integrated molecular characterization provides a comprehensive foundation for developing PCC/PGL precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,669
Self-citationMutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Self-citationMermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. L., Beroukhim, R., & Getz, G. (2011) · Genome Biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,550
Self-citationAbsolute quantification of somatic DNA alterations in human cancer
Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., Laird, P. W., Onofrio, R. C., Winckler, W., Weir, B. A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2203 · Cited by 2,053
Self-citationMapSplice: Accurate mapping of RNA-seq reads for splice junction discovery
Wang, K., Singh, D., Zeng, Z., Coleman, S. J., Huang, Y., Savich, G. L., He, X., Mieczkowski, P., Grimm, S. A., Perou, C. M., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq622 · Cited by 1,193
Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer
Gross, M. I., Demo, S. D., Dennison, J. B., Chen, L., Chernov-Rogan, T., Goyal, B., Janes, J. R., Laidig, G. J., Lewis, E. R., Li, J., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0870 · Cited by 1,068
Self-citationSDH mutations establish a hypermethylator phenotype in paraganglioma
Letouzé, E., Martinelli, C., Loriot, C., Burnichon, N., Abermil, N., Ottolenghi, C., Janin, M., Menara, M., Nguyen, A. T., Benit, P., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.018 · Cited by 776 · cited 2×
“…subtype also contained two of the three unsupervised clusters of DNA methylation (hypermethylated and intermediate), confirming earlier reports (Letouze et al., 2013), with most SDHB and SDHD germline mutations occurring in the hypermethylated subtype and nearly all VHL and EPAS1mutations in…”
ResultSelf-citationGenetic Testing in Pheochromocytoma or Functional Paraganglioma
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 684
Self-citationComprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., Lerario, A. M., Else, T., Knijnenburg, T. A., Ciriello, G., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.002 · Cited by 657
Self-citationHypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation
Huang, X., Ding, L., Bennewith, K. L., Tong, R. T., Welford, S. M., Ang, K. K., Story, M., Le, Q.-T., & Giaccia, A. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.006 · Cited by 617
Frequent ATRX , CIC , FUBP1 and IDH1 mutations refine the classification of malignant gliomas
Jiao, Y., Killela, P. J., Reitman, Z. J., Rasheed, B. A., Heaphy, C. M., de Wilde, R. F., Rodriguez, F. J., Rosemberg, S., Oba-Shinjo, S. M., Nagahashi Marie, S. K., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.588 · Cited by 584
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity
Dahia, P. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3648 · Cited by 545
Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors
Flynn, R. L., Cox, K. E., Jeitany, M., Wakimoto, H., Bryll, A. R., Ganem, N. J., Bersani, F., Pineda, J. R., Suvà, M. L., Benes, C. H., et al. (2015) · Science · doi:10.1126/science.1257216 · Cited by 506
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine
Favier, J., Amar, L., & Gimenez-Roqueplo, A.-P. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.188 · Cited by 490
Self-citationA HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
Dahia, P. L. M., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010008 · Cited by 443
Self-citationAyala-Ramirez, M., Feng, L., Johnson, M. M., Ejaz, S., Habra, M. A., Rich, T., Busaidy, N., Cote, G. J., Perrier, N., Phan, A., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1946 · Cited by 428
Occurrence of Pheochromocytoma in Rochester, Minnesota, 1950 Through 1979
Beard, A. M., Sheps, S. G., Kurland, L. T., Carney, J. A., & Lie, J. T. (1983) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)18873-3 · Cited by 402
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Zhuang, Z., Yang, C., Lorenzo, F., Merino, M., Fojo, T., Kebebew, E., Popovic, V., Stratakis, C. A., Prchal, J. T., & Pacak, K. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205119 · Cited by 397
Eisenhofer, G., Lenders, J. W. M., Siegert, G., Bornstein, S. R., Friberg, P., Milosevic, D., Mannelli, M., Linehan, W. M., Adams, K., Timmers, H. J., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.07.016 · Cited by 334
Self-citationIntegrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Burnichon, N., Vescovo, L., Amar, L., Libé, R., de Reynies, A., Venisse, A., Jouanno, E., Laurendeau, I., Parfait, B., Bertherat, J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr324 · Cited by 309
Self-citationEisenhofer, G., Lenders, J. W., Timmers, H., Mannelli, M., Grebe, S. K., Hofbauer, L. C., Bornstein, S. R., Tiebel, O., Adams, K., Bratslavsky, G., et al. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.153320 · Cited by 290
Statistical Significance of Clustering for High-Dimension, Low–Sample Size Data
Liu, Y., Hayes, D. N., Nobel, A., & Marron, J. S. (2008) · Journal of the American Statistical Association · doi:10.1198/016214508000000454 · Cited by 267
Self-citationMulti-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas
Castro-Vega, L. J., Letouzé, E., Burnichon, N., Buffet, A., Disderot, P.-H., Khalifa, E., Loriot, C., Elarouci, N., Morin, A., Menara, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7044 · Cited by 196
Self-citationWhole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
Fishbein, L., Khare, S., Wubbenhorst, B., DeSloover, D., D’Andrea, K., Merrill, S., Cho, N. W., Greenberg, R. A., Else, T., Montone, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms7140 · Cited by 185
Self-citationABRA: improved coding indel detection via assembly-based realignment
Mose, L. E., Wilkerson, M. D., Hayes, D. N., Perou, C. M., & Parker, J. S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu376 · Cited by 177
Self-citationSafely targeting cancer stem cells via selective catenin coactivator antagonism
Lenz, H., & Kahn, M. (2014) · Cancer Science · doi:10.1111/cas.12471 · Cited by 175
Comino-Méndez, I., de Cubas, A. A., Bernal, C., Álvarez-Escolá, C., Sánchez-Malo, C., Ramírez-Tortosa, C. L., Pedrinaci, S., Rapizzi, E., Ercolino, T., Bernini, G., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt069 · Cited by 169
Self-citationMcElhinny, A., Li, J., & Wu, L. (2008) · Oncogene · doi:10.1038/onc.2008.228 · Cited by 168
Eukaryotic cold shock domain proteins: highly versatile regulators of gene expression
Mihailovich, M., Militti, C., Gabaldón, T., & Gebauer, F. (2010) · BioEssays · doi:10.1002/bies.200900122 · Cited by 165
Crona, J., Verdugo, A. D., Maharjan, R., Stalberg, P. L. H., Granberg, D. O., Hellman, P., & Björklund, P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4257 · Cited by 160
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
Burnichon, N., Buffet, A., Parfait, B., Letouzé, É., Laurendeau, I., Loriot, C., Pasmant, É., Abermil, N., Valeyrie‐Allanore, L., Bertherat, J. Y., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds374 · Cited by 159
Self-citationEnlund, F., Behboudi, A., Andrén, Y., et al. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.09.007 · Cited by 155
Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma
Wang, X., Bledsoe, K. L., Graham, R. P., Asmann, Y. W., Viswanatha, D. S., Lewis, J. E., Lewis, J. T., Chou, M. M., Yaszemski, M. J., Jen, J., et al. (2014) · Nature Genetics · doi:10.1038/ng.2989 · Cited by 155
Toledo, R. A., Qin, Y., Cheng, Z.-M., Gao, Q., Iwata, S., Silva, G. M., Prasad, M. L., Ocal, I. T., Rao, S. N., D, N. A. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1841 · Cited by 153
Hescot, S., Leboulleux, S., Amar, L., Vezzosi, D., Borget, I., Bournaud, C., de la Fouchardière, C., Libé, R., Cao, C. D., Niccoli, P., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1907 · Cited by 123
Self-citationAlves‐Guerra, M., Ronchini, C., & Capobianco, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1720 · Cited by 99
Figlioli, G., Landi, S., Romei, C., Elisei, R., & Gemignani, F. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.09.002 · Cited by 91
Succinate: A New Epigenetic Hacker
Yang, M. H., & Pollard, P. J. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.015 · Cited by 86
The genomic landscape of phaeochromocytoma
Flynn, A., Benn, D. E., Clifton-Bligh, R. J., Robinson, B. G., Trainer, A. H., James, P. A., Hogg, A., Waldeck, K., George, J., Li, J., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4503 · Cited by 83
Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma
Welander, J., Stenman, A., Brauckhoff, M., Bäckdahl, M., Larsson, C., Gimm, O., & Söderkvist, P. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0384 · Cited by 82
Integrated RNA and DNA sequencing improves mutation detection in low purity tumors
Wilkerson, M. D., Cabanski, C. R., Sun, W., Hoadley, K. A., Walter, V., Mose, L. E., Troester, M. A., Hammerman, P. S., Parker, J. S., Perou, C. M., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku489 · Cited by 82
Self-citationPRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors
Berthon, A. S., Szarek, E., & Stratakis, C. A. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00026 · Cited by 69
Elatmani, H., Dormoy-Raclet, V., Dubus, P. R., Dautry, F., Chazaud, C., & Jacquemin‐Sablon, H. (2011) · Stem Cells · doi:10.1002/stem.712 · Cited by 64
Komminoth, P., Kunz, E. K., Hiort, O., Schröder, S., Matías‐Guiu, X., Christiansen, G., Roth, J., & Heitz, P. U. (1994) · PubMed Central · Cited by 61
Dormoy-Raclet, V., Markovits, J., Malato, Y., Huet, S., Lagarde, P., Montaudon, D., Jacquemin‐Sablon, A., & Jacquemin‐Sablon, H. (2006) · Oncogene · doi:10.1038/sj.onc.1210068 · Cited by 51
Bílek, R., Šafařík, L., Ciprová, V., Vlček, P., & Lisá, L. (2008) · Physiological Research · doi:10.33549/physiolres.931502 · Cited by 47
Amelio, A. L., Fallahi, M., Schaub, F. X., Zhang, M., Lawani, M. B., Alperstein, A. S., Southern, M. R., Young, B. M., Wu, L., Zajac‐Kaye, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319176111 · Cited by 35
Self-citationAnalysis of Selected Genes in Neuroendocrine Tumours: Insulinomas and Phaeochromocytomas
Hrašćan, R., Pećina‐Šlaus, N., Martić, T. N., Čolić, J. F., Gall‐Tros̆elj, K., Pavelić, K., & Karapandža, N. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01755.x · Cited by 29
The control of precerebellar neuron migration by RNA-binding protein Csde1
Kobayashi, H., Kawauchi, D., Hashimoto, Y., Ogata, T., & Murakami, F. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.055 · Cited by 27
Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
Heynen, G. J. J. E., Nevedomskaya, E., Palit, S. A. L., Basheer, N. J., Lieftink, C., Schlicker, A., Zwart, W. T., Bernards, R., & Bajpe, P. K. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0291-t · Cited by 23
Genetic aberrance of sporadic MEN 2A component tumours: analysis of RET
Cho, N. H., Lee, H. W., Lim, S. Y., Kang, S., Jung, W. Y., & Park, C. S. (2005) · Pathology · doi:10.1080/00313020400024816 · Cited by 13
Cited by
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Chandrashekar, D. S., Bashel, B., Balasubramanya, S. A. H., Creighton, C. J., Ponce-Rodriguez, I., Chakravarthi, B. V. S. K., & Varambally, S. (2017) · Neoplasia · doi:10.1016/j.neo.2017.05.002 · Cited by 6,086
Landscape of Microsatellite Instability Across 39 Cancer Types
Bonneville, R., Krook, M. A., Kautto, E. A., Miya, J., Wing, M. R., Chen, H.-Z., Reeser, J. W., Yu, L., & Roychowdhury, S. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00073 · Cited by 1,476
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Zhang, Y., Shi, J., Liu, X., Feng, L., Gong, Z., Koppula, P., Sirohi, K., Li, X., Wei, Y., Lee, H., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0178-0 · Cited by 1,013
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
Pozdeyev, N., Gay, L. M., Sokol, E. S., Hartmaier, R., Deaver, K. E., Davis, S., French, J. D., Borre, P. V., LaBarbera, D. V., Tan, A.-C., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0373 · Cited by 533
Self-citationTargeting the HIF2–VEGF axis in renal cell carcinoma
Choueiri, T. K., & Kaelin, W. G. (2020) · Nature Medicine · doi:10.1038/s41591-020-1093-z · Cited by 477
Metadata
- Authors
- Fishbein, L., Leshchiner, I., Walter, V., Danilova, L., Robertson, A. G., Johnson, A. R., Lichtenberg, T. M., Murray, B. A., Ghayee, H. K., Else, T., Ling, S., Jefferys, S. R., de Cubas, A. A., Wenz, B., Korpershoek, E., Amelio, A. L., Makowski, L., Rathmell, W. K., Gimenez-Roqueplo, A.-P., Giordano, T. J., Asa, S. L., Tischler, A. S., Pacak, K., Nathanson, K. L., Wilkerson, M. D., Akbani, R., Ally, A., Amar, L., Amelio, A. L., Arachchi, H., Asa, S. L., Auchus, R. J., Auman, J. T., Baertsch, R., Balasundaram, M., Balu, S., Bartsch, D. K., Baudin, E., Bauer, T., Beaver, A., Benz, C., Beroukhim, R., Beuschlein, F., Bodenheimer, T., Boice, L., Bowen, J., Bowlby, R., Brooks, D., Carlsen, R., Carter, S., Cassol, C. A., Cherniack, A. D., Chin, L., Cho, J., Chuah, E., Chudamani, S., Cope, L., Crain, D., Curley, E., Danilova, L., de Cubas, A. A., de Krijger, R. R., Demchok, J. A., Deutschbein, T., Dhalla, N., Dimmock, D., Dinjens, W. N. M., Else, T., Eng, C., Eschbacher, J., Fassnacht, M., Felau, I., Feldman, M., Ferguson, M. L., Fiddes, I., Fishbein, L., Frazer, S., Gabriel, S. B., Gardner, J., Gastier-Foster, J. M., Gehlenborg, N., Gerken, M., Getz, G., Geurts, J., Ghayee, H. K., Gimenez-Roqueplo, A.-P., Giordano, T. J., Goldman, M., Graim, K., Gupta, M., Haan, D., Hahner, S., Hantel, C., Haussler, D., Hayes, D. N., Heiman, D. I., Hoadley, K. A., Holt, R. A., Hoyle, A. P., Huang, M., Hunt, B., Hutter, C. M., Jefferys, S. R., Johnson, A. R., Jones, S. J. M., Jones, C. D., Kasaian, K., Kebebew, E., Kim, J., Kimes, P., Knijnenburg, T., Korpershoek, E., Lander, E., Lawrence, M. S., Lechan, R., Lee, D., Leraas, K. M., Lerario, A., Leshchiner, I., Lichtenberg, T. M., Lin, P., Ling, S., Liu, J., LiVolsi, V. A., Lolla, L., Lotan, Y., Lu, Y., Ma, Y., Maison, N., Makowski, L., Mallery, D., Mannelli, M., Marquard, J., Marra, M. A., Matthew, T., Mayo, M., Méatchi, T., Meng, S., Merino, M. J., Mete, O., Meyerson, M., Mieczkowski, P. A., Mills, G. B., Moore, R. A., Morozova, O., Morris, S., Mose, L. E., Mungall, A. J., Murray, B. A., Naresh, R., Nathanson, K. L., Newton, Y., Ng, S., Ni, Y., Noble, M. S., Nwariaku, F., Pacak, K., Parker, J. S., Paul, E., Penny, R., Perou, C. M., Perou, A. H., Pihl, T., Powers, J., Rabaglia, J., Radenbaugh, A., Ramirez, N. C., Rao, A., Rathmell, W. K., Riester, A., Roach, J., Robertson, A. G., Sadeghi, S., Saksena, G., Salama, S., Saller, C., Sandusky, G., Sbiera, S., Schein, J. E., Schumacher, S. E., Shelton, C., Shelton, T., Sheth, M., Shi, Y., Shih, J., Shmulevich, I., Simons, J. V., Sipahimalani, P., Skelly, T., Sofia, H. J., Sokolov, A., Soloway, M. G., Sougnez, C., Stuart, J., Sun, C., Swatloski, T., Tam, A., Tan, D., Tarnuzzer, R., Tarvin, K., Thiessen, N., Thorne, L. B., Timmers, H. J., Tischler, A. S., Tse, K., Uzunangelov, V., van Berkel, A., Veluvolu, U., Vicha, A., Voet, D., Waldmann, J., Walter, V., Wan, Y., Wang, Z., Wang, T. S., Weaver, J., Weinstein, J. N., Weismann, D., Wenz, B., Wilkerson, M. D., Wise, L., Wong, T., Wong, C., Wu, Y., Yang, L., Zelinka, T., Zenklusen, J. C., Zhang, J. (., Zhang, W., Zhu, J., Zinzindohoué, F., & Zmuda, E.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 31
- Issue
- 2
- Pages
- 181-193
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2585589460
- Cited by
- 789
- References
- 52
- FWCI
- 63.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.